← SynDRA
BAVISANT
SynDRA canonical compound SYN0030062 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HRH3 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH3 ANTAGONIST
- Histamine H3 receptor antagonist
Cross-references
Synonyms
- JNJ-31001074
- bavisantum
- RefChem:916750
- DTXCID70207943
- UNII-9827P7LFVH
- Bavisant [USAN:INN]
- Bavisant [USAN]
- Bavisant (USAN/INN)
- BAVISANT [INN]
- BAVISANT [WHO-DD]
- SCHEMBL522603
- orb1296246
- BGBVSGSIXIIREO-UHFFFAOYSA-N
- EMB62208
- BDBM50089371
- BDBM50138125
- EX-A10460
- MFCD19443732
- CS-1457
- EBC-8040892
- HY-14880
- TS-10641
- DB-110687
- NS00072138
- D09870
- G92152
- BRD-K79595931-312-01-3
- JNJ-31001074-AAC
- Bavisant dihydrochloride hydrate
- CS-1459
- HY-14880B
- MFCD26142923
- DA-71301
- BAVISANT DIHYDROCHLORIDE MONOHYDRATE [WHO-DD]
- Bavisant dihydrochloride [USAN]
- D09871
- bavisant dihydrochloride hydrate
- AKOS030526253
Look up BAVISANT in the interactive SynDRA portal →